Search Results
Results found for "Brigitte Kieffer"
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
By understanding how different SNPs affect β2AR function, it becomes possible to tailor therapies based
- Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...
neuronal Gα proteins of GOA-1, GSA-1, and GPA-10 functioned to transduce signals of multiple GPCRs to different
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Hilger, D., et al., Structural insights into differences in G protein activation by family A and family
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
These dimeric interactions may contribute to the phenomenon of biased agonism, where ligands produce different
- 📰 GPCR Weekly News - January 9 to 15, 2023
GPCRs in Cardiology, Endocrinology, and Taste Gender Differences in GRK2 in Cardiovascular Diseases and
- Decoding β-Arrestins: from Structure to function
multiple structures of activated b-arrestins in complex with the carboxyl terminus phosphopeptides of different Additionally, not all receptors recruit both isoforms equally and arrestins can undergo different conformational
- Exploring the Breakthroughs in GPCR Research
free fatty acid receptor 4 as a regulator of food and water intake The tick Ixodes scapularis has five different
- 📰 GPCR Weekly News, December 4 to 10, 2023
in promoting yolk globule fusion and regulating oocyte maturation 19F-NMR studies of the impact of different
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
keratinocytes are susceptible to apoptosis via GPCR-Gβγ-pERK signal pathways Chemogenetic engagement of different
- From DNA day to GPCR genomics
provided insights into the expression patterns and post-translational modifications of GPCRs under different
- Therapeutic validation of an orphan G protein‐coupled receptor
GPR84 has been additionally proposed to be a potential biomarker in different inflammatory diseases (
- 📰 GPCR Weekly News, March 11 to 17, 2024
Obesity GPCRs in Neuroscience Xanthurenic acid: A role in brain intercellular signaling Are there sex differences
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
The right information at the right time can mean the difference between a breakthrough and a dead end
- Advantages of Fluorescent Probes in GPCR Assays
Our proprietary conjugation technology also facilitates the synthesis of different linker sizes and types
- 📰 GPCR Weekly News, May 27 to June 2, 2024
dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons A new GRAB sensor reveals differences
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
high-throughput DNA sequencing with systematic mutagenesis to create and assess the impact of many different
- GPCR Buzz of the Week | Sep 23 - 29, 2024
Registrants will learn: The powerful applications of new cellular assays to determine GPCR ligand behavior in different
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Registrants will learn: The powerful applications of new cellular assays to determine GPCR ligand behavior in different
- Nanobodies: New Dimensions in GPCR Signaling Research
rhodopsin receptor activation and investigate the role of specific regions in the switching between different
- Regulators of G-protein signaling: essential players in GPCR signaling
Besides the differences in their structural complexity, some members of the RGS family are selective
- Targeting Intracellular Allosteric Sites in GPCRs
Interestingly, although having different chemical structures they exhibit strikingly similar binding
- Glyco-sulfo hotspots in the chemokine receptor system
For CCR5, it has been shown that N-terminal antibodies show different sulfo-sensitivities (Scurci I et
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
The cellular context is crucial for understanding the diverse signaling outcomes mediated by different
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
across the whole spectrum of signaling activity are identified: full antagonists, partial agonists with different receptor antagonist analogs have demonstrated powerful efficacies across a range of animal models spanning different
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
While they share similarities, there are notable differences in respect to neural network architecture